Effect of the epidermal growth factor receptor antibody panitumumab on triggering of ADCC

T. Valerius,M. Dechant,J. J. Lammerts van Bueren,Tanja Schneider-Merck,Sven Berger,Thomas Beyer,Martin Gramatzki,Wim K. Bleeker,Paul Parren,J.G.J. van de Winkel

Effect of the epidermal growth factor receptor antibody panitumumab on triggering of ADCC

2009

T. Valerius
M. Dechant
J. J. Lammerts van Bueren
Tanja Schneider-Merck
Sven Berger
Thomas Beyer
Martin Gramatzki
Wim K. Bleeker
Paul Parren
J.G.J. van de Winkel

11055 Targeted therapy against the epidermal growth factor receptor (EGF-R) has been introduced into clinical practice for several solid tumors. Thus far, EGF-R- directed antibodies have received a...

Keywords:

Antibody-dependent cell-mediated cytotoxicity
Epidermal Growth Factor Receptor Antibody
Panitumumab
Cancer research
Chemistry
Antibody
Targeted therapy
Medicine
Clinical Practice
Epidermal growth factor receptor
Pathology

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations